Yahoo Web Search

Search results

  1. May 8, 2024 · London, 8 May 2024 – Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, has launched Midazolam Injection, USP, in 2mg/2mL and 10mg/2mL doses. The product has been launched in the US in a prefilled syringe form and is indicated for: intramuscularly or intravenously for preoperative sedation/anxiolysis/amnesia;

    • Home

      Hikma has strong start to 2024, with continued momentum...

    • About

      Hikma enters the Spanish generic injectables market,...

    • Products

      We manufacture and bring patients across North America, MENA...

    • Investors

      Hikma enters the Spanish generic injectables market,...

    • Newsroom

      Newsroom - Hikma launches Midazolam Injection, USP, in a...

  2. 6 days ago · Stock analysis for Hikma Pharmaceuticals PLC (HIK:London) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

    • 8.8K
  3. May 21, 2024 · Hikma Pharmaceuticals PLC specializes in developing, producing, and selling drugs used in treating cardiovascular diseases, infections, cancers, diabetes, etc. Net sales break down by family of products as follows: - generic injectable products (45.3%); - brand name drugs (27.5%); - generic products taken orally (26.7%); - other (0.5%).

    • (11)
    • HIKMA PHARMACEUTICALS PLC
  4. 5 days ago · About Hikma Pharmaceuticals. Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.

  5. 5 days ago · Latest Hikma Pharmaceuticals PLC (HIK:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more.

    • 1,750.00
    • 1,763.00
    • 1,807.00
    • 1,786.00
    • Hikma Pharmaceuticals1
    • Hikma Pharmaceuticals2
    • Hikma Pharmaceuticals3
    • Hikma Pharmaceuticals4
    • Hikma Pharmaceuticals5
  6. People also ask

  7. 3 days ago · Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. Show more.

  8. May 20, 2024 · A high-level overview of Hikma Pharmaceuticals PLC (HKMPF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

  1. People also search for